More Seroquel suits dropped on Delaware ruling

Two more cases have been dismissed in Delaware in the sprawling litigation over AstraZeneca's antipsychotic drug Seroquel, as plaintiffs' attorneys voluntarily dismissed cases that had been set for trial in November. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.